Aditxt (ADTX) announced the acquisition of Ignite Proteomics. Under the terms of the transaction documents, Aditxt acquired Ignite in a transaction providing 36,000 shares of Aditxt’s newly designated Series A-2 Convertible Preferred Stock, representing an aggregate stated value of $36M, subject to the terms of the Certificate of Designation.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX:
- Upcoming Stock Splits This Week (March 9 to March 13) – Stay Invested
- ADiTx Therapeutics trading halted, news pending
- Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing
- Aditxt to effect 1-for-8 reverse split of common stock
- Aditxt Holders Approve Share Issuances, Reverse Split Flexibility